...D round led by Domain Associates, which invested through its Fund VIII. Also participating were Lumira Capital... ...Phase II study of CTX-4430 to treat moderately severe acne vulgaris. Domain Associates' Nicole Vitullo, Lumira Capital's...
...D round led by Domain Associates, which invested through its Fund VIII. Also participating were Lumira Capital... ...Phase II study of CTX-4430 to treat moderately severe acne vulgaris. Domain Associates' Nicole Vitullo, Lumira Capital's...